RLAY
Relay Therapeutics Inc
18.70$
-3.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -299.2% | – | -502.9% | – | – | – | -953.4% | -8,162.6% | – | -640.9% | -1,703.7% | -15,459.7% | -2,050.3% | |
| 5.4% | – | 13.9% | – | – | – | 15.7% | -57.9% | – | -3.7% | 16.8% | 102.9% | 13.1% | |
| 86.6% | – | 271.7% | – | – | – | 251.7% | 2,141.8% | – | 186.7% | 351.2% | 2,622.6% | 466.8% | |
| -114.2% | – | 79.7% | – | – | – | -196.4% | -282.0% | – | -40.3% | 397.3% | 5,909.4% | 254.0% | |
| 2.3% | – | 17.8% | – | – | – | 5.0% | 3.8% | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| 283.2% | – | 105.2% | – | – | – | 553.0% | 11,099.9% | – | 506.6% | 1,096.7% | -100,864.6% | -2,366.5% | |
| – | – | – | – | – | – | – | 96.5% | – | 6.1% | – | – | – | |
| 37.5% | – | 488.9% | – | – | – | 0.0% | 96.5% | – | 13.3% | 4,626.1% | 92,495.7% | 4,478.0% | |
| 21.5% | – | 91.2% | – | – | – | -400.4% | 3,033.7% | – | -121.0% | 4,019.0% | -23,828.6% | 61.1% | |
| -301.5% | – | -520.7% | – | – | – | -958.4% | -8,166.5% | – | -640.9% | -1,703.7% | -15,459.7% | -2,050.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.